Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000930413-24-002268
Filing Date
2024-08-08
Accepted
2024-08-08 16:24:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 c109631_sc13g.htm SC 13G 57965
  Complete submission text file 0000930413-24-002268.txt   59596
Mailing Address 2 OVERHILL ROAD SCARSDALE NY 10583
Business Address 2 OVERHILL ROAD SCARSDALE NY 10583 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

EIN.: 010786483 | State of Incorp.: DE
Type: SC 13G

Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Subject) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89366 | Film No.: 241188806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)